Biotech

All Articles

Novo inks $600M NanoVation offer to study hereditary medications ex-liver

.Novo Nordisk is actually proceeding its push right into genetic medications, agreeing to compensate...

Innovent links cytokine to colorectal cancer cells responses

.Innovent Biologics has made the instance that its gate inhibitor-cytokine fusion healthy protein po...

Merck, Daiichi ADC attacks objective in period 3 bronchi cancer cells study

.A phase 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina deepens artificial intelligence concentrate with collab to select cancer aim ats

.5 months after Rakovina Rehabs pivoted towards expert system, the cancer-focused biotech has actual...

Ascendis' dwarfism medicine hits in phase 3, intimidates BioMarin

.Ascendis Pharma has emerged as a possible hazard to BioMarin's Voxzogo, reporting stage 3 growth ai...

Despite ph. 3 miss, Alkeus views path ahead for eye disease asset

.Though Alkeus Pharmaceuticals' oral eye health condition possession fell short to dramatically decr...

Kairos goes public with $6M IPO to finance trials of cancer cells medicine

.With a trio of biotechs reaching the Nasdaq on Friday, it was actually very easy to miss a smaller-...

Vaccine and also Keytruda combination efficient in squamous tissue carcinoma

.Immune system checkpoint inhibitors are actually the superheroes of cancer treatment. Medications l...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings a...

Regeneron's Opdualag competitor reveals 57% feedback cost

.Regeneron is back with long-term follow-up for its own LAG-3 inhibitor as well as PD-1 prevention c...